New Immunization Requirements for 2017-18
New Requirements for the 2017-18 School Year for Incoming 7-12 Graders
Meningococcal Secondary School Vaccine Requirement
For the 2017-2018 school year, and all future school years, all students entering, advancing or transferring into 7th grade and born a er September 15, 2004, will need proof of one dose of meningococcal conjugate vaccine (MenACWY). All students entering, advancing, or transferring into 12th grade and born a er Septem- ber 15, 1999, will need proof of two doses of meningococcal (A, C W, Y) vaccine; or 1 dose if received when the student was 16 years of age or older.
Meningi s vaccine protect against meningococcal serogroups A, C, W, and Y. Meningococcal disease caused by any serogroup is very serious, life-threatening illness. It is caused by bacteria that can infect the blood, brain, and spinal cord. Meningococcal bacteria are spread through upper respiratory droplets, such as saliva (kissing, living in close quarters). About 10 to 15% of people with meningococcal disease die even with appropriate treatment. Twenty percent of people recovering from meningococcal disease su er from serious e ects including permanent hearing loss, limb loss, or brain damage. Meningococcal vaccines are very safe and e ec ve at preven ng meningococcal disease. The meningococcal vaccine is 85 – 100 percent e ec ve at preven ng infec on from the subtypes of meningococcus found in the vaccine.